Comprehensive eicosanoid panel.

VG Vikas B. Gubbala
NJ Nidhi Jytosana
VT Vincent Q. Trinh
HM H. Carlo Maurer
RN Razia F. Naeem
NL Nikki K. Lytle
ZM Zhibo Ma
SZ Steven Zhao
WL Wei Lin
HH Haiyong Han
YS Yu Shi
TH Tony Hunter
PS Pankaj K. Singh
KO Kenneth P. Olive
MT Marcus C.B. Tan
SK Susan M. Kaech
GW Geoffrey M. Wahl
KD Kathleen E. DelGiorno
ask Ask a question
Favorite

Eicosanoid profiling was conducted on flash-frozen pancreas tissue from wild type mice (C57B6/J or CD1), KPC mice, or orthotopic tumors (cell lines FC-1199, FC-1242, and FC-1245) grown in C57B6/J mice. In separate experiments, eicosanoid profiling was performed on flash frozen human PDAC or normal pancreas. Age-matched normal and PanIN-bearing pancreata were included from a previous study4. Tissues were homogenized in 1 ml of PBS containing 10% ethanol and 300 μl were extracted using strata-x polymeric reverse phase columns (88-S100-UBJ Phenomenex). Samples were taken up in 50 μl of 63% H20, 37% ACN, 0.02% Acetic Acid, and 10 μl was injected into UPLC (ACQUITY UPLC System, Waters) and analyzed on a Sciex 6500 Qtrap mass spectrometer at the UCSD Lipidomics Core as previously described37. Tissue eicosanoid concentrations were quantified using deuterated internal standards in conjunction with standard curves obtained in parallel using identical conditions as previously described38, and were normalized to total protein mass of the sample.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A